ADVANCED SOFT TISSUE SARCOMA
Clinical trials for ADVANCED SOFT TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOFT TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED SOFT TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to outsmart tough cancers
Disease control Recruiting nowThis study is testing whether adding two newer immunotherapy drugs to a standard chemotherapy drug (doxorubicin) can help control advanced soft tissue sarcoma for longer. It will enroll about 65 adults with specific types of this cancer who have not had certain prior treatments. …
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Radioactive drug trial offers hope for Tough-to-Treat sarcomas
Disease control Recruiting nowThis early-stage study is testing a new radioactive drug, [Ac225]RTX-2358, for people with advanced soft tissue sarcoma that has come back or hasn't responded to other treatments. The main goals are to find the safest and most effective dose and to see if the drug helps control t…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New Two-Drug attack tested for Tough-to-Treat sarcomas
Disease control Recruiting nowThis study is testing a new treatment approach for people with advanced soft tissue sarcomas, including leiomyosarcoma and dedifferentiated liposarcoma. It aims to find the safest dose and best schedule for combining the drug abemaciclib with chemotherapy (gemcitabine). The main …
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for rare cancer: Two-Drug attack on tough sarcoma
Disease control Recruiting nowThis study is testing if a combination of two drugs, atezolizumab and selinexor, can shrink tumors in patients with advanced alveolar soft part sarcoma, a rare and difficult-to-treat cancer. The trial is for patients whose cancer has continued to grow despite prior immunotherapy.…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
New hope for Tough-to-Treat sarcomas: Dual-Attack drug trial
Disease control Recruiting nowThis trial is testing whether combining two existing cancer drugs—pembrolizumab and cabozantinib—can help control advanced sarcomas that have stopped responding to standard treatments. It will enroll about 119 adults with specific types of advanced sarcoma. The main goal is to se…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Can a 'Maintenance' drug keep advanced sarcoma at bay?
Disease control Recruiting nowThis study is for people with advanced soft tissue sarcoma whose cancer has been controlled by initial chemotherapy. It compares two approaches: receiving a maintenance chemotherapy drug (pegylated liposomal doxorubicin) every 4 weeks versus taking a break from treatment with clo…
Matched conditions: ADVANCED SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Mar 09, 2026 14:27 UTC